載入...
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
BACKGROUND: Direct-acting antivirals (DAAs) dramatically improve the treatment of hepatitis C virus (HCV) infections. However, the effects of DAAs on extra-hepatic manifestations such as HCV-associated glomerulonephritis, especially in cases with renal dysfunction, are not well elucidated. CASE PRES...
Na minha lista:
| 發表在: | BMC Nephrol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5372252/ https://ncbi.nlm.nih.gov/pubmed/28356063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0534-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|